Tests Innovations : GA Generic Assays GmbH

CytoBead® Technology

The first combination assay for screening and differentiation in the field of cell-based and bead-based immunofluorescence, for the diagnosis of systemic and organ specific autoimmune diseases.

Anti-ASGPR

Enzyme immunoassay for the semi-quantitave determination of IgG antibodies against the membrane receptor of asialoglycoproteins, in human serum or plasma.

Anti-Factor H

Enzyme immunoassay for the quantitive determination of IgA antibodies against complement factor H (CFH) in human serum, for the differential diagnosis of atypical hemolytic uremic syndrome (HUS).

Anti-GP2 IgG / Anti-GP2 IgA

Enzyme immunoassay for the quantitative determination of IgG or IgA antibodies against glycoprotein 2 (GP2) in human serum.

Line immunoassay for the determination of antibody profiles (IgG or IgM) against phospholipids and serum proteins, in human serum or plasma.Unique membrane-based assay for the profile diagnostics of anti-phospholipid antibodies.

Anti-Gangliosid Dot

Line immunoassay for the determination of antibody profiles (IgG or IgM) against gangliosides, in human serum, plasma or CSF.